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Abstract: The ionic liquid catalyst 3-sulfonic acid-1-imidazolopyridinium hydrogen sulfate, [Simp]HSO4 was found to be a highly active and green 
catalyst for the synthesis of 3,4-dihydropyrimidin-2(1H)-ones (thiones) under the solvent-free conditions. Avoiding organic solvents during the 
chemical reactions leading to an economic approach is effective. The reactions are characterized by high efficiency, short reaction time, high 
product yield, simple experimental procedure, availability of catalyst, and environmentally-friendly reaction conditions. 
 




INTRODUCTION AND RESULTS 
,4-DIHYDROPYRIMIDIN-2(1H)-ONES (DHPMs) belong 
to an important class of heterocyclic compounds, have 
attracted much interest due to their pharmacological and 
biological properties such as the anti-hypertensive, calcium 
channel blocking, anti-tumor, anti-bacterial, and anti-
inflammatory activities.[1,2] The pyrimidine derivative MKC-
442 is already in clinical trials and similar compounds are 
expected to inhibit the HIV virus.[3] Moreover, several 
marine alkaloids whose molecular structures contain the 
3,4-dihydropyrimidin-2(1H)-ones core, also exhibit inte-
resting biological activities.[4] Therefore, the synthesis of 
these compounds is still of great importance. 
 The earliest method for the synthesis of 3,4-
dihydropyrimidin-2(1H)-ones reported by Biginelli in 1893, 
involved the one-pot condensation of an aldehyde, an α,β-
ketoester, and urea under strongly acidic conditions with 
low product yields (often 20–50 %)[5] Although there are 
different methods for the synthesis of Biginelli’s products 
based on the use of strong protic acids such as  HCl,[6] Lewis 
acids like BF3.OEt2,[7] zeolites,[8] and metal trifles[9] a variety 
of other conditions such as the ultrasonic,[10] and 
microwave-assisted[11] also have been reported in the 
literature. 
 However, many of these methods suffer from 
drawbacks such as the use of expensive reagents, strongly 
acidic conditions, long reaction times, and use of expensive 
and poisonous solvents. Therefore, the introduction of 
more efficient and milder methods accompanied with 
higher product yields is in demand. In recent years, with 
increase in the environmental consciousness in chemical 
research and industry, the solvent-free Biginelli reaction 
has attracted much attention and received good results 
recently.[12,13] 
 Ionic liquids have fascinated much interest in the 
past few decades because of their unique properties 
including high thermal and chemical stability, non-
volatility, non-flammability, favorable solvation behavior, 
and wide range of liquid-state temperatures.[14] These 
compounds have been extensively applied to the extraction 
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Brønsted acidic ionic liquids are environmentally friendly, 
efficient, and simple acid catalysts, and  have been used in 
various organic transformations.[16–18] 
 Now, in continuation of our works on the synthesis 
of heterocyclic compounds,[19–21] we wish to report the use 
of the naturally-based ionic liquid 3-sulfonic acid-1-
imidazolopyridinium hydrogen sulfate, [Simp]HSO4, as a 
catalyst in the eco-friendly and practical synthesis of  3,4-
dihydropyrimidin-2(1H)-ones (thiones) via a one-pot, 
three-component condensation of aromatic aldehydes, 
α,β-dicarbonyl compound and urea or thiourea under the 
solvent-free conditions (Scheme 1). 
 The ionic liquid 3-sulfonic acid-1-imidazolopy-
ridinium hydrogen sulfate [Simp]HSO4 has been prepared 
by the reaction of chlorosulfonic acid with caffeine 
previously and was characterized thoroughly and has been 
used as a catalyst for the synthesis of 2H-indazolo[2,1-
b]phthalazine-1,6,11(13H)-triones.[21] In order to optimize 
the reaction conditions, the reaction of benzaldehyde 1a, 
with ethyl acetoacetate 2a and urea 3a was chosen as a 
model reaction in the absence and presence of the 
[Simp]HSO4 catalyst in order to establish the effectiveness 
of the catalyst under the thermal solvent-free conditions 
(Table 1). 
 It was found that the product 4a was produced in a 
low yield after 4 h in the absence of the [Simp]HSO4 catalyst 
(Table 1, entry 1), whereas 1 mol% of the catalyst led to a 
98 % product yield after 45 min (Table 1, entry 3). As shown 
in Table 1, this transformation required the presence of the 
catalyst, and, therefore, to optimize the reaction 
conditions, the above-mentioned model reaction was 
carried out under different reaction conditions. The yield of 
the corresponding 3,4-dihydropyrimidin-2(1H)-one 4a 
increased with increase in the catalyst concentration from 
0.5 to 1.0 mol% (Table 1, entries 2 and 3). Further addition 
of the catalyst had no noticeable effect on the product yield 
(Table 1, entries 4 and 5). Therefore, in all the further 
reactions 1.0 mol% of the catalyst was used. The reaction 
Table 1. Investigation of catalyst effects and temperature in the synthesis of 5-(Ethoxycarbonyl)-6-methyl-4-phenyl-3,4-
dihydropyrimidin-2(1H)-one under solvent-free conditions(a) 
Entry Catalyst amount (mol%) Temperature (ºC ) Time (min) Yields (%)(b) 
1 0 50 360 30 
2 0.5 50 45 80 
3 1.0 50 45 98 
4 2.0 50 45 98 
5 3.0 50 45 99 
6 1.0 r.t 360 40 
7 1.0 80 45 98 
(a) Reaction conditions: benzaldehyde (1.0 mmol), ethyl acetoacetate (1.0 mmol), urea (1.2 mmol). 
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yield was susceptible to temperature changes in the 
presence of 1.0 mol% of the catalyst under the solvent-free 
conditions. It was found that at room temperature, the 
reaction proceeded slowly, giving a low product yield (Table 
Table 2. Solvent effect on the reaction of benzaldehyde, ethyl acetoacetate and urea     catalyzed by [Simp]HSO4.(a) 
Entry Solvent (reflux) Time (h) Yields (%)(b) 
1 CH3CN 10 55 
2 EtOH 10 50 
3 THF 10 35 
4 H2O 10 45 
5 1,4-Dioxan 10 65 
6 Tolouene 10 60 
7 Solvent-free 0.75 98 
(a) Reaction conditions: benzaldehyde (1.0 mmol), ethyl acetoacetate (1.0 mmol), urea (1.2 mmol). 
(b) Isolated yields. 
 
Table 3. Synthesis of 3,4-dihydropyrimidin-2-(1H)-ones (thiones) 4(a) 
Entry Ar R X Product Time (min) Yield (%)(b) [ref.] 
1 Ph OEt O 4a 45 98 [23] 
2 4-Me-C6H4 OEt O 4b 50 80 [24] 
3 4-MeO-C6H4 OEt O 4c 60 70 [24] 
4 2,3,4-(MeO)3-C6H2 OEt O 4d 20 50 This work 
5 4-Cl-C6H4 OEt O 4e 30 60 [24] 
6 2-Cl-C6H4 OEt O 4f 120 98 [25] 
7 4-NO2-C6H4 OEt O 4g 120 60 [26] 
8 4-CHO-C6H4 OEt O 4h 30 97 [27] 
9 Ph OEt S 4i 30 36 [26] 
10 2-Me-C6H4 OEt S 4j 60 98 [28] 
11 4-MeO-C6H4 OEt S 4k 30 92 [26] 
12 4-Cl-C6H4 OEt S 4l 300 98 [26] 
13 2-Cl-C6H4 OEt S 4m 300 40 [29] 
14 4-CHO-C6H4 OEt S 4n 45 85 [30] 
15 Ph Me O 4o 40 55 [23] 
16 4-Me-C6H4 Me O 4p 45 97 [23] 
17 2,3,4-(MeO)3-C6H2 Me O 4q 15 60 This work 
18 4-Cl-C6H4 Me O 4r 30 40 [23] 
19 2-Cl-C6H4 Me O 4s 30 53 [29] 
20 4-CHO-C6H4 Me O 4t 30 90 [27] 
21 Ph Me S 4u 30 80 [23] 
22 4-Me-C6H4 Me S 4v 35 98 [23] 
23 4-Cl-C6H4 Me S 4w 60 97 [29] 
24 2-Cl-C6H4 Me S 4x 40 98 [29] 
25 4-CHO-C6H4 Me S 4y 30 93 [27] 
(a)Reaction conditions: Aromatic aldehyde (1.0 mmol), α,β-dicarbonyl compound (1.0 mmol) urea or thiourea (1.2 mmol), catalyst (0.01 mmol), solvent-free, 
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1, entry 6). The increase in the reaction temperature up to 
50 ºC led to an excellent yield (Table 1, entry 3). 
 To check the solvent effect on the outcome of the 
reaction, the above-mentioned model reaction was carried 
out using 1.0 mol% of the catalyst in solvents such as 
CH3CN, EtOH, THF, H2O, 1,4-dioxan, and toluene under the 
reflux conditions (Table 2). All the screened solvents 
afforded low product yields after 10 h. It is noteworthy that 
when THF was used as the solvent, a lower product yield 
was observed (Table 2, entry 3). The best product yield was 
obtained under the solvent-free conditions at 50 °C (Table 
2, entry 7). Thus all the reactions were performed in the 
presence of 1 mol% of the catalyst at 50 °C under the 
solvent-free conditions. 
 To extend the scope of the reaction, and to 
generalize the procedure, we investigated the reactions of 
a series of aromatic aldehydes with urea (thiourea) and 
ethyl acetoacetate or acetylacetone under the optimized 
reaction conditions. In all the cases studied, the three-
component reaction proceeded smoothly to give the 
corresponding 3,4-dihydropyrimidin-2(1H)-ones (thiones) 
with satisfactory yields. The aromatic aldehydes carrying 
either electron-donating or electron- withdrawing 
substituents at the ortho, meta, and para positions 
afforded high yields of 3,4-dihydropyrimido-2(1H)-ones. An 
important feature of this procedure is the survival of a 
variety of functional groups such as nitro, chloro, methyl, 
and methoxy under the reaction conditions. In addition 
thiourea reacted under similar reaction conditions to form 
the corresponding 3,4-dihydropyrimido-2(1H)-thiones in 
good to excellent yields (Table 3). 
 In order to show the merit of this catalytic method, 
the results obtained for the reactions of benzaldehyde, 
ethyl acetoacetate, urea, (Table 4) were compared with 
those obtained for some other catalysts used for the same 
reactions. Most of the listed methodologies suffer from 
some limitations such as prolonged reaction times, 
elevated temperatures, and use of hazardous materials. For 
example, preparation of 3,4-dihydropyrimido-2(1H)-one 4a 
was carried out in the hazardous CH3CN (Table 4, entries 1, 
and 2). Additionally, the present protocol was effective in 
the synthesis of compound 4a in a reaction time of 45 min. 
The same transformation required 3-6 h for completion by 
using other catalysts. As it is evident in the results tabulated 
in Table 4, [Simp]HSO4 is more efficient than the other 
catalysts. 
 In conclusion, in this work, a catalytic amount of 
[Simp]HSO4 was used very effectively, for the first time, for 
a solvent-free, high yield, and rapid synthesis of 3,4-
dihydropyrimido-2(1H)-ones (thiones). This method is very 
general and tolerates different types of functional groups. 
Based on our studies, this method offers several 
advantages including the cheapest materials, mild reaction 
conditions, high product yield, shorter reaction time, very 




Melting points were recorded on an electrothermal type 
9100 melting point apparatus. IR spectra were obtained on 
a 4300 Shimadzu spectrometer as KBr disk. 1H-NMR spectra 
were recorded on a Bruker BRX 400 AVANCE spectrometer. 
Elemental analysis results were obtained using a Thermo 
Finnigan Flash EA microanalyser. 
Preparation of 3-sulfonic Acid-1-
imidazolopyridinium Hydrogen Sulfate 
[Simp]HSO4 
To a 100 mL round-bottomed flask containing caffeine 
(0.9710 g, 5 mmol) in dry CH2Cl2 (50 mL), was added 
chlorosulfonic acid (0.59 g, 5.1 mmol) drop-wise over a 
period of 20 min at room temperature. After the addition 
was completed, the reaction mixture was stirred for 12 h. The 
residue was washed with dry CH2Cl2 (3 × 50 mL) and dried to 
give 3-sulfonic acid imidazolopyridinium chloride ([Simp]Cl) 
as a viscous pale yellow oil. Then sulfuric acid (98 %) (0.49 g, 
5 mmol) was added drop-wise to [Simp]Cl (1.55 g, 5 mmol) 
over a period of 5 min at room temperature to remove the 
HCl produced during the reaction. Finally, the resulting 
mixture was stirred for 24 h at 60 °C under the aerobic 
conditions to give [Simp]HSO4 as a viscous yellow oil.[22] 
Table 4. Comparison of protocols for the synthesis of 3,4-dihydropyrimidin-2(1H)-one 4a(a) 
Entry  Catalyst Condition Time  [ref.]Yield (%)  
1 O12PMo3H CN ,80°C3CH 1 h 93 [30] 
2 2/SiO40O12PW3H ,80°CCN 3CH 50 min [31]97  
3 H3SO-3O2Fe-γ-Nano Solvent-free, 60 °C  3 h [25]95  
4 11HPVMo  EtOH, 80°C  6 h  [32]95  
5 COOH3CH  MW 7 min 84 [33] 
6 4HClO MW, 240 W, solvent-free 2 min [34]95  
7 [Simp]HSO4 Solvent-free, 50 °C 45 min 98 [a] 
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General Procedure for the Synthesis of 
3,4-dihydropyrimidin-2(1H)-ones 
(thiones) 
A mixture of an aromatic aldehyde (1.0 mmol), ethyl 
acetoacetate (1.0 mmol, 0.13 mL) or acetylacetone (1.0 
mmol, 0.1 mL), urea(1.2 mmol, 0.072 g), or thiourea (1.2 
mmol, 0.086 g), and [Simp]HSO4 (0.01 mmol, 0.004 g) was 
heated at 50 °C for an appropriate time (Table 3).  After 
completion of the reaction, the residue was washed with 
water for several times. The filtrate was recrystallized from 
ethanol to afford the pure product. 
Ethyl 1,2,3,4-tetrahydri-6-methyl-oxo-4- 
phenylpyrimidine-5-carboxylate (4a): 
White solid, (98 %); m.p.= 205–207; 1H NMR (400 MHz, 
DMSO-d6) δ/ppm: 1.01 (t, J = 7.2 Hz, 3H, CH3CH2O), 2.25 
(s, 3H, CH3), 3.98 (q, J = 7.2 Hz, 2H, CH2,), 5.14 (s, 1H, C4H), 
7.24–7.40 (m, 3H, C'3-H, C'4-H, C'5-H), 7.33-7.54 (m, 2H, 
C'2-H, C'6-H), 7.73 (s, 1H, NH), 9.18 (s, 1H, NH); 13C NMR 
(100 MHz DMSO-d6) δ/ppm: 14.1 (CH3), 18.5 (CH3-C6), 
55.5 (CH2), 59.9 (C4), 101.2 (C5), 126.5 (C'4), 127.8 (C'2), 
128.6 (C'3), 143.7 (C'1), 146.4 (C6), 153.7 (C2), 165.6 (C=O); 
Anal. Calcd. for C14H16N2O3: C, 64.60; H, 6.20; N, 10.76. 
Found: C, 64.41; H, 6.32; N, 10.59. 
Ethyl 1,2,3,4-tetrahydro-6-methyl-2-oxo-4-p-
tolylpyrimidine-5-carboxylate (4b): 
White solid, (80 %); m.p.= 212–214; 1H NMR (400 MHz, 
DMSO-d6) δ/ppm: 1.15 (t, J = 7.2 Hz, 3H, CH3CH2O), 2.3 (s, 
3H, CH3), 4.04 (q, J = 7.2 Hz, 2H, CH2), 5.34 (s, 1H, C4H), 6.22 
(s, 1H, NH), 7.05–7.16 (m, 4H, C'2-H, C'3-H, C'5-H, C'6-H), 
8.75 (s, 1H, NH); 13C NMR (100 MHz DMSO-d6) δ/ppm: 
14.1(CH3), 18.5 (CH3-C6), 21.0 (CH3-C'4), 55.1 (CH2), 59.8 
(C4), 101.2 (C5), 126.4 (C'4), 129.2 (C'2), 137.5 (C'3), 140.8 
(C'1), 146.4 (C6), 153.9 (C2), 165.6 (C=O); Anal. Calcd. for 
C15H18N2O3: C, 65.68; H, 6.61; N, 10.21. Found: C, 65.85; H, 
6.51; N, 10.38. 
Ethyl 1,2,3,4-tetrahydro-4-(2,3,4-trimethoxyphenyl)-6-
methyl-2-oxopyrimidine-5-carboxylate (4d): 
White solid, (50 %); m.p.= 195–197; 1H NMR (400 MHz, 
DMSO-d6) δ/ppm: 1.13 (t, 3H, J = 7.2 Hz, CH3CH2O), 2.43 
(s, 3H, CH3), 3.85 (s, 3H, OCH3), 3.88 (s, 3H, OCH3), 3.98 (s, 
3H, OCH3), 4.08 (q, 2H, J = 7.2 Hz, CH2), 5.54 (s, 1H, C4H), 
6.58 (d, 1H, J = 8.8 Hz, C'5H), 6.78 (d, 1H, J = 8.8 Hz, C'6H), 
7.30 (s, 1H, NH), 8.01 (s, 1H, NH). 13CNMR (100 MHz, DMSO-
d6) δ/ppm: 8.9 (CH3), 13.3 (CH3-C6), 44.8 (CH2), 50.7 (C4), 
54.6 (OCH3), 55.5 (OCH3), 55.9 (OCH3), 101.6 (C5), 115.9 
(C'1), 122.7 (C'6), 136.9 (C'3), 142.6 (C'4), 145.8 (C'2), 148.0 
(C6), 148.3 (C2), 160 (C=O); Anal. Calcd. for C17H22N2O6: C, 
58.28; H, 6.33; N, 8.00. Found: C, 58.47; H, 6.43; N, 8.16. 
Ethyl 4-(4-chlorophenyl)-1,2,3,4-tetrahydro-6-methyl-2-
oxopyrimidine-5-carboxylate (4e): 
White solid, (60 %); m.p.= 211–213; 1H NMR (400 MHz, 
DMSO-d6) δ/ppm: 1.10 (t, 3H, J = 7.2 Hz, CH3CH2O), 2.25 
(s, 3H, CH3), 3.98 (q, J = 7.2 Hz, 2H, CH2), 5.14 (s, 1H, C4H), 
7.25 (d, 2H, J = 8.4 Hz, C'2-H,C'6H), 7.40 (d, 2H, J = 8.4 Hz, 
C'3-H, C'5H), 7.76 (s, 1H, NH), 9.24 (s, 1H, NH); 13C NMR (100 
MHz DMSO-d6) δ/ppm: 14.1 (CH3), 18.6(CH3-C6), 55.0 
(CH2), 60.2 (C4), 101.0 (C5), 127.9 (C'2), 128.8 (C'3), 133.7 
(C'4), 142.1 (C'1), 146.5 (C6), 153.5(C2), 165.3 (C=O); Anal. 
Calcd. for C14H15ClN2O3: C, 57.05; H, 5.13; N, 9.50. Found: C, 
57.22; H, 5.221; N, 9.66. 
Ethyl 4-(2-chlorophenyl)-1,2,3,4-tetrahydro-6-methyl-2-
oxopyrimidine-5-carboxylate (4f): 
White solid, (98 %); m.p.= 213–215; 1H NMR (400 MHz, 
DMSO-d6) δ/ppm: 1.02 (t, 3H, CH3CH2O); 2.45 (s, 3H, CH3), 
3.98 (q, J = 7.2 Hz, 2H, CH2), 5.83 (s, 1H, C4H), 5.95 (s, 1H, 
NH), 7.20-7.35 (m, 4H, C'3-H, C'4-H, C'5-H, C'6-H), 9.02 (s, 
1H, NH); 13C NMR (100 MHz DMSO-d6) δ/ppm: 13.9 
(CH3),18.2 (CH3-C6), 52.0 (CH2), 59.9 (C4), 98.8 (C5), 127.5 
(C'5), 128.0 (C'3), 129.3 (C'4), 129.7(C'6), 132.4 (C'2), 139.6 
(C'1), 148.6 (C6), 153.4 (C2), 165.4 (C=O); Anal. Calcd. for 
C14H15ClN2O3: C, 57.05; H, 5.13; N, 9.50. Found: C, 57.24; H, 
5.03; N, 9.67. 
Ethyl 4-(4-formylphenyl)-1,2,3,4-tetrahydro-6-methyl-2-
oxopyrimidine-5-carboxylate (4h): 
White solid, (97 %); m.p.= 275–277; 1H NMR (400 MHz, 
DMSO-d6) δ/ppm: 1.06 (t, 6H, J = 6.9 Hz, 2 CH3CH2O), 2.19 
(s, 6H, 2CH3), 4.01 (q, 4H, J = 6.9 Hz, 2CH2), 5.14 (s, 2H, 
2C4H), 7.19 (s, 4H, C'2-H, C'3-H, C'5-H, C'6-H), 9.60 (s, 2H, 
2NH), 10.3 (s, 2H, 2NH); 13C NMR (100 MHz DMSO-d6) δ
/ppm: 14.2 (CH3), 18.5 (CH3-C6), 55.1 (CH2), 59.9 (C4), 102.0 
(C5), 126.9 (C'2), 142.2 (C'1), 146.6 (C6), 152.5(C2), 166.3 
(C=O); Anal. Calcd. for C22H26N4O6: C, 59.72; H, 5.92; N, 
12.66. Found: C, 59.53; H, 5.80; N, 12.85. 
5-Acetyl-3,4-dihydro-6-methyl-4-p-tolylpyrimidin-2(1H)-
one (4p): 
White solid, (97 %); m.p.= 252–254; 1H NMR (400 MHz, 
DMSO-d6) δ/ppm: 2.08 (s, 3H, CH3-C6). 2.25 (s, 3H, CH3-
C'4), 2.27 (s, 3H, CH3-CO), 5.22 (s, 1H, C4H), 7.12-7.24 (m, 
4H, C'2-H, C'3-H, C'5-H, C'6-H), 7.75 (s, 1H, NH), 9.13 (s, 1H, 
NH); 13C NMR (100 MHz DMSO-d6) δ/ppm: 19.1(CH3-C6), 
21.5 (CH3-C'4), 31.2 (CH3-CO), 54.7 (C4), 110.2 (C5), 127.4 
(C'4), 130.2 (C'2), 137.5 (C'3), 142.8 (C'1), 149.4 (C6), 153.2 
(C2), 195.6 (C=O). Anal. Calcd. for C14H16N2O2: C, 68.83; H, 
6.60; N, 11.47. Found: C, 68.65; H, 6.71; N, 11.30. 
5-Aacetyl-3,4-dihydro-4-(2,3,4-trimethoxyphenyl)-6-
methylpyrimidin-2(1H)-one (4q): 
White solid, (60 %); m.p.= 170–172; 1H NMR (400 MHz, 
DMSO-d6) δ/ppm: 2.08 (s, 3H, CH3), 2.41 (s, 3H, CH3-CO), 
3.84 (s, 3H, OCH3), 3.87 (s, 3H, OCH3), 4.04 (s, 3H, OCH3), 5.65 
(s, 1H, C4H), 6.57 (d, 1H,  J = 8.8 Hz,C'5H), 6.75 (d, 1H, J = 8.8 
Hz, C'6H), 7.20 (s, 1H, NH), 8.59 (s, 1H, NH). 13CNMR (100 
MHz, DMSO-d6) δ/ppm: δ 14.1 (CH3-C6), 24.3 (CH3-CO), 50.7 
(C4), 54.8 (OCH3), 55.5 (OCH3), 55.7 (OCH3), 101.6 (C5), 116.1 
(C'5), 119.8 (C'1), 121.8 (C'6) , 136.7 (C'3), 142.5 (C'4), 148.2 
(C6), 148.7 (C2), 190.2 (C=O). Anal. Calcd. for C16H20N2O5: C, 
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White solid, (98 %); m.p.= 213–215; 1H NMR (400 MHz, 
DMSO-d6) δ/ppm: 2.11 (s, 3H, CH3-C6), 2.30 (s, 3H, CH3-
C'4), 3.70 (s, 3H, CH3-CO), 5.24 (s, 1H, C4H), 6.90–7.10 (m, 
4H, C'2-H, C'3-H, C'5-H, C'6-H), 9.68 (s, 1H, NH), 10.21 (s, 1H, 
NH); 13C NMR (100 MHz DMSO-d6) δ/ppm: 19.1(CH3-C6), 
21.2 (CH3-C'4), 31.4 (CH3-CO), 56.7 (C4), 111.2 (C5), 127.3 
(C'4), 128.3 (C'2), 136.0 (C'3), 145.4 (C'1), 159.1 (C6), 174.2 
(C2), 195.6 (C=S); Anal. Calcd. for C14H16N2OS: C, 64.58; H, 




White solid, (98 %); m.p.= 175–177; 1H NMR (400 MHz, 
DMSO-d6) δ/ppm: 2.07 (s, CH3-C6), 2.32 (s, 3H, CH3-CO), 
5.65 (s, 1H, C4H), 7.18–7.33 (m, 3H, C'4-H, C'5-H, C'6-H), 
7.35–7.37 (m, 1H, C'3-H), 9.60 (s, 1H, NH), 10.30 (s, 1H, NH); 
13C NMR (100 MHz DMSO-d6) δ/ppm: 18.6 (CH3-C6), 30.7 
(CH3-CO), 52.3 (C4), 110.1 (C5), 128.5 (C'5), 129.0 (C'3), 
130.1 (C'4), 132.3 (C'6), 140.1 (C'1), 145.3 (C6), 174.4 (C2), 
195.2 (C=S); Anal. Calcd. for C13H13ClN2OS: C, 55.61; H, 4.67; 
N, 9.98; S, 11.42. Found: C, 55.42; H, 4.75; N, 9.81; S, 11.59. 
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